EquityFolio

EDVA

AMEX Healthcare

Endovia Health Sciences, Inc.

$0.19

$0.00 (+1.32%)

Live quote

52w: $0.17 – $13.40

Loading chart…
P/E Ratio—
P/B Ratio—
EV/EBITDA—
Debt/Equity—
ROE—
ROIC—
Revenue Growth-90.88%
Gross Margin23.13%
Endovia Health Sciences is a diversified cannabinoid-based health sciences platform. The company's strategy focuses on three main areas: commercializing differentiated cannabinoid-based pharmaceutical products internationally, advancing cannabinoid-based human and veterinary therapeutics through U.S. regulatory pathways, and developing consumer wellness and beverage products. This marks a strategic transformation from its prior operations as a beverage company.

Own EDVA? Track it here.

Create a free account to add EDVA to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account